Progressive Supranuclear Palsy (PSP): Clinical Trials

1 trial for Progressive Supranuclear Palsy (PSP), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Progressive Supranuclear Palsy (PSP): new trials by email Literature Review of Progressive Supranuclear Palsy (PSP) trials Research Report on Progressive Supranuclear Palsy (PSP)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP)
ABBV-8E12, Placebo solution for IV infusion on Day 15 - Progressive Supranuclear Palsy (PSP)
Phase 2TerminatedAbbVie1422018-01-242021-02-03

Narrower conditions

Supranuclear Palsy, Progressive (1)  ·  Tauopathies (1)

Broader conditions

Basal Ganglia Diseases (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cranial Nerve Diseases (1)  ·  Eye Diseases (1)  ·  Movement Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurodegenerative Diseases (1)  ·  Neurologic Manifestations (1)  ·  Ocular Motility Disorders (1)  ·  Ophthalmoplegia (1)  ·  Paralysis (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

tilavonemab (1)

Sponsors

AbbVie (1)

Countries

Australia (1)  ·  Canada (1)  ·  Italy (1)  ·  Japan (1)  ·  United States (1)

NIH funding

2017 (1)